Skip to main content
. Author manuscript; available in PMC: 2021 May 10.
Published in final edited form as: Am J Addict. 2019 Jan 21;28(2):71–76. doi: 10.1111/ajad.12858

TABLE 3.

Estimated mean differences in cocaine-free days between topiramate and placebo among BIS-11 subscores

Estimated mean difference (%) Lower 95% C.I. Upper 95% C.I. p-value Bonferroni corrected p-value
Second-order
 Attentional
  >Median 3.32 −6.24 12.87 0.495 0.990
  ≤Median 11.92 2.66 21.18 0.012 0.024
 Motor
  >Median 4.98 −4.76 14.72 0.316 0.632
  ≤Median 10.81 1.53 20.09 0.023 0.046
 Nonplanning
  >Median 7.82 −2.65 18.28 0.143 0.286
  ≤Median 8.04 −0.62 16.71 0.069 0.138
First-order
 Attention
  >Median 3.28 −7.16 13.70 0.536 0.999
  ≤Median 11.37 2.62 20.12 0.011 0.022
 Cognitive
  >Median 6.37 −5.52 18.27 0.293 0.586
Instability
  ≤Median 7.50 −0.50 15.49 0.066 0.132
 Motor
  >Median 6.45 −4.01 16.91 0.226 0.452
  ≤Median 8.23 −0.36 16.82 0.060 0.120
 Perseverance
  >Median 11.64 0.36 22.92 0.043 0.086
  ≤Median 5.42 −2.72 13.55 0.191 0.382
 Self-control
  >Median 13.64 3.22 24.05 0.010 0.020
  ≤Median 4.32 −4.18 12.82 0.318 0.636
 Cognitive
  >Median 5.98 −5.08 17.03 0.288 0.576
 Complexity
  ≤Median 8.78 0.57 16.98 0.036 0.072

Bold values indicate statistical significance p < 0.05.